As a result, KKR will become the largest non-index fund shareholder in the Company with a 12% position, demonstrating the firm’s confidence in Henry Schein, its management team, and its BOLD+1 ...

Henry Schein and KKR will collaborate on a range of value-creation opportunities. Henry Schein will issue new shares of common stock to funds affiliated with KKR for a $250 million investment ...

Jan 29 (Reuters) - Private equity firm KKR (KKR.N), opens new tab has taken a large stake in Henry Schein (HSIC.O), opens new tab and reached a deal to add members to the company's board ...

KKR to invest $250M in Henry Schein, increasing stake to 12%, with an option to reach 14.9%. Henry Schein raises share buyback program by $500M and expects moderate revenue and EPS growth in 2025.

Henry Schein (NASDAQ:HSIC) announced Wednesday a strategic investment from funds affiliated with private equity firm KKR (NYSE:KKR) and released its preliminary Q4 2024 financials and full-year ...

Private equity firm KKR increased its stake in Henry Schein Inc., investing $250 million in the company to help boost financial performance, according to the Melville-based company. The investment ...

Henry Schein (HSIC) announced a strategic investment by funds affiliated with KKR,(KKR) a global investment firm.In addition to KKR’s current holdings, KKR will make an additional $250M ...

(Reuters) -Private equity firm KKR has taken a large stake in Henry Schein and reached a deal to add members to the company's board, the distributor of medical products said on Wednesday.

KKR & Co. has taken a 12% stake in Henry Schein Inc. and will work with the company to improve operations at the world’s largest distributor of medical products to office-based dentists and doctors.